| Patents for C07D 277 - Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings (33,621) |
|---|
| 04/29/2008 | US7365068 Hepatitis C virus infections; -(3-cyclopropyl-4-(pentyloxy)phenyl)-3-nicotinoylthiourea;methyl 2-oxo-2-(5-((3-(4-(pentyloxy)-3-(trifluoromethyl)phenyl)thioureido)carbonyl)pyridin-2-ylamino)acetate |
| 04/29/2008 | CA2343204C Arylsulfonanilide ureas |
| 04/24/2008 | WO2008047694A1 Process for production of benzothiazole compound |
| 04/24/2008 | WO2007032028A8 Thiazolinones and oxazolinones and their use as ptp1b inhibitors |
| 04/24/2008 | US20080097106 Halogenated benzamide derivatives |
| 04/24/2008 | US20080097105 Biphenyl-2-ylcarbamic Acid 1-{9-[2-(4-Hydroxy-2-oxo-2,3-dihydrobenzothiazol-7-yl)-ethylamino]nonyl}piperidin-4-yl Ester Bis(trifluoroacetate) Salt; chronic obstructive pulmonary disease, asthma; bronchodilators |
| 04/24/2008 | US20080096940 5-Hydroxy-Benzothiazole Derivatives Having Beta-2-Adrenoreceptor Agonist Activity |
| 04/24/2008 | US20080096939 Process For Preparation Of Pramipexole By Chiral Chromatography |
| 04/24/2008 | US20080096938 Immunosuppressants for autoimmune diseases such as multiple sclerosis, transplant rejection; sphingosine-1-phosphate (S1P) receptor agonists; (S)-2-Amino-2-(5-(4-(2-(pentyloxy)ethoxy)-3-(trifluoromethyl)phenyl)-1,3,4-thiadiazol-2-yl)propyl dihydrogen phosphate for example |
| 04/24/2008 | US20080096937 For example, 2-{4-[(2-chloro-benzyl)-ethyl-amino]-phenyl}-1,1,1,3,3,3-hexafluoro-propan-2-ol; the compounds bind to and selectively activate LXR alpha and LXR beta; used to treat diseases such as atherosclerosis and diabetes |
| 04/24/2008 | US20080096936 Sulfur substituted sulfonylaminocarboxylic acid N-arylamides, their preparation, their use and pharmaceutical preparations comprising them |
| 04/24/2008 | US20080096911 Biphenyl-2-ylcarbamic Acid 1-{9-[2-(4-Hydroxy-2-oxo-2,3-dihydrobenzothiazol-7-yl)-ethylamino]nonyl}piperidin-4-yl Ester Bis(trifluoroacetate) Salt; chronic obstructive pulmonary disease, asthma; bronchodilators |
| 04/24/2008 | US20080096883 Trifluoromethyl substituted benzamides as kinase inhibitors |
| 04/24/2008 | US20080096877 Glucokinase activators; prophylaxis or treatment of diabetes, obesity; sulfonamide or sulfonate-functional thiazole or thiadiazole-substituted indoles; N,N-dimethyl-2-{4-[(2-{7-[methyl(2-thienylsulfonyl)amino]-1H-indol-2-yl}-1,3-thiazol-5-yl)methyl]piperazin-1-yl}acetamide for example |
| 04/24/2008 | US20080096876 Histamine receptor antagonists; 4-[3-(4-Piperidin-1-yl-but-1-ynyl)-benzyl]-thiomorpholine; antiallergens, antihistamines, antiepileptic agents; asthma, alzheimer's disease, narcolepsy, motion sickness, attention deficit disorder, schizophrenia |
| 04/24/2008 | US20080096869 Adamantyl acetamides as 11-beta hydroxysteroid dehydrogenase inhibitors |
| 04/23/2008 | EP1914225A1 Salt molten at room temperature and display device |
| 04/23/2008 | EP1912982A2 Novel heterocyclic nf- b inhibitors |
| 04/23/2008 | EP1912959A2 5-substituted thiazol-2-yl amino compounds and compositions as protein kinase inhibitors |
| 04/23/2008 | EP1912497A1 Fungicidal n-[2-(haloalkoxy)phenyl]heteroarylcarboxamides |
| 04/23/2008 | EP1812412B1 Substituted benzoylguanidines method for production and use thereof as medicament or diagnostic and medicament comprising the same |
| 04/23/2008 | EP1303483B1 Novel thiourea derivatives and the pharmaceutical compositions containing the same |
| 04/23/2008 | EP1219612B1 2-imino-1,3-thiazine derivatives |
| 04/23/2008 | EP0984928B1 Heterocyclic nitrato derivatives |
| 04/23/2008 | CN101166534A Therapeutic agent for chronic obstructive pulmonary disease |
| 04/23/2008 | CN100383132C Azoles as malonyl-COA decarboxylase inhibitors useful as metabolic modulators |
| 04/23/2008 | CN100383131C Process for synthesizing 2-p-trifluoro toluene-4-methyl-5-thiazolyl ethyl formate |
| 04/22/2008 | US7361769 Metabolic disorders, eating disorders such as hyperphagia, and diabetes |
| 04/22/2008 | US7361681 Method of treating amytrophic lateral sclerosis using melatonin |
| 04/22/2008 | US7361679 Integrin VLA-4 ( alpha 4 beta 1) and/or integrin LPAM-1 ( alpha 4 beta 7) antagonists, cell adhesion inhibitor; bioavailability, oral administration;treating inflammatory diseases; e.g. 3-[2-(2,6-dichlorobenzoylamino)pyrid-5-yl]-2-{3-[(2,2-dimethylpropionyl)isobutylamino]-4-methoxyphenyl}propionic acid |
| 04/22/2008 | US7361676 Solid preparation containing single crystal form |
| 04/22/2008 | US7361671 E.g.,(6-Ethyl-3-(4,5,7-trifluoro-benzothiazol-2-ylmethyl)-pyrr (2,3-b)pyridin-1-yl)acetic acid; interacts with and inhibits aldose reductase; antidiabetic agents and diabetic complications; gout; hypoglycemic and antiarthritic |
| 04/22/2008 | US7361655 Pharmaceutically effective compounds |
| 04/22/2008 | CA2388759C Substituted piperazine derivatives, the preparation thereof and their use as medicaments |
| 04/22/2008 | CA2350137C New piperazine and di-dehydropiperidine compounds |
| 04/22/2008 | CA2210693C Pyrazol-4-yl-benzoyl derivatives and their use as herbicides |
| 04/22/2008 | CA2180816C 6-dimethylaminomethyl-1-phenyl-cyclohexane compounds as pharmaceutical active ingredients |
| 04/17/2008 | WO2008044767A1 Aromatic amine derivative and use thereof |
| 04/17/2008 | WO2008043567A1 2-phenyl indene derivatives useful as estrogen receptor ligands |
| 04/17/2008 | WO2008006625A3 Derivatives of urea and related diamines, methods for their manufacture, and uses therefor |
| 04/17/2008 | WO2008002570B1 Human protein tyrosine phosphatase inhibitors and methods of use |
| 04/17/2008 | WO2007115836A3 Tetrahydronaphtol-derivatives and use thereof |
| 04/17/2008 | US20080091025 Reduces the operating voltage and inhibits the molecules from being crystallized by using an aromatic amine derivative having a sulfur atom, an oxygen atom, a selenium atom, or a tellurium atom substituent for a hole transporting material; enhances yield in device, improves lifetime |
| 04/17/2008 | US20080090882 Heterocyclic Carbonyl Compounds |
| 04/17/2008 | US20080090854 Cxcr2 inhibitors |
| 04/17/2008 | US20080090840 Heterocyclic GPR40 Modulators |
| 04/17/2008 | US20080090829 5-{2-[2-(4-Tert-Butyl- phenyl)-oxazol-4-yl]-ethylsulfamoyl}-2-methyl-benzoic acid methyl ester; used as peroxisome proliferator activator receptor agonist, to increase high density lipoproteins and lower LDL-cholesterol and triglycerides; treatment of atherosclerosis, cardiovascular, metabolic disorders |
| 04/17/2008 | US20080090782 Inhibit DNA-dependent protein kinase; reduced side effects caused by radiation and chemotherapy drugs |
| 04/17/2008 | US20080090779 2-Benzyloxy-5-(2-bromoacetyl)-N-[3,5-bis(trifluoromethyl)phenyl-benzamide; diseases caused by production of immunoglobulin E: inflammatory cytokine, histamine, leukotriene and degranulation from activated mast cell; pollinosis, bronchial asthma, atopic dermatitis, urticaria; endometriosis, hysteromyoma |
| 04/17/2008 | US20080087884 A benzene or polycondensed aromatic ring substituted with substituted thiazole groups; storage stability and high ON current |
| 04/17/2008 | US20080087327 Organic dye, photoelectric conversion material, semiconductor electrode and photoelectric conversion device |
| 04/17/2008 | CA2666177A1 Acylaminoimidazoles and acylaminothiazoles |
| 04/16/2008 | EP1911751A1 Amide derivative and pesticide containing such compound |
| 04/16/2008 | EP1911750A1 Agent for improvement in bounce/body of hair, and hair cosmetic |
| 04/16/2008 | EP1911740A1 Potassium channel modulators |
| 04/16/2008 | EP1911446A2 The use of PPAR-gamma agonists for treating diseases characterised by neuron degeneration, neuron injury or impaired plasticity |
| 04/16/2008 | EP1911350A1 Amidine compound and herbicide |
| 04/16/2008 | EP1910351A1 Colourless water-soluble organic luminophores and intermediates thereof |
| 04/16/2008 | EP1910325A2 New pharmaceutical compounds |
| 04/16/2008 | EP1910312A1 Quadratic acid ii derivatives |
| 04/16/2008 | EP1910304A2 Therapeutic agents |
| 04/16/2008 | EP1799690B1 Thiazolyl-dihydro indazoles |
| 04/16/2008 | EP1534334A4 Releasable polymeric conjugates based on aliphatic biodegradable linkers |
| 04/16/2008 | CN101163662A Phenylacetylene derivatives having mglur5 receptor affinity |
| 04/16/2008 | CN101161641A Tricyclic steroid hormone nuclear receptor modulators |
| 04/16/2008 | CN100381566C Recombinant methods and materials for producing epothilone and eopthilone derivatives |
| 04/16/2008 | CN100381438C New pyrrolidine and thiazolidine compounds, process for their preparation and pharmaceutical compositions containing them |
| 04/16/2008 | CN100381430C Process for producing substituted alkylamines or salts thereof |
| 04/16/2008 | CN100381429C Thiazole derivatives |
| 04/16/2008 | CN100381424C Biaryl sulfonamides and methods for using same |
| 04/15/2008 | US7358386 Indane acetic acid derivatives and their use as pharmaceutical agents, intermediates, and method of preparation |
| 04/15/2008 | US7358373 Cathepsin K inhibitors |
| 04/15/2008 | US7358364 Substituted carboxylic acids |
| 04/15/2008 | US7358344 Azo dye |
| 04/15/2008 | US7358267 2-(pyrazol-1-yl)thiazole compounds; obesity and type II diabetes; modulators of the mitochondrial protein uncoupling protein 3 (UCP3); treating retinoid X receptor (RXR) modulated conditions; 2-(4-carboxy-5-methylpyrazol-1-yl)-4-(p-trifluoromethylphenyl)thiazole |
| 04/15/2008 | US7358266 Cyclopropyl and cyclobutyl epothilone analogs |
| 04/15/2008 | US7358264 Statine derivatives for the treatment of Alzheimer's disease |
| 04/15/2008 | US7358263 Fused bicyclic-substituted amines as histamine-3 receptor ligands |
| 04/15/2008 | US7357989 Di(het)arylaminothiazole derivatives and their use in organic light-emitting diodes(OLEDs) and organic photovoltaic components |
| 04/10/2008 | WO2008042497A2 Benzoxazole and benzothiazole compounds useful as authentication compounds in polymer articles |
| 04/10/2008 | WO2008041240A1 Process for preparing (s)-pramipexole and its intermediates |
| 04/10/2008 | WO2008040979A1 Arginine derivatives with np-i antagonistic activity |
| 04/10/2008 | WO2007125105A3 Benzamide glucokinase activators |
| 04/10/2008 | WO2007125103A3 Benzamide glucokinase activators |
| 04/10/2008 | US20080085924 Amidobiphenyloxime derivatives, useful as fungicide or bactericide for protection of crops and materials |
| 04/10/2008 | US20080085894 Alpha-(n-sulfonamido)acetamide derivatives as beta-amyloid inhibitors |
| 04/10/2008 | CA2664842A1 Arginine derivatives with np-i antagonistic activity |
| 04/09/2008 | EP1907387A1 An oxime derivative and preparations thereof |
| 04/09/2008 | EP1907369A1 Thiazoles derivatives as ampk activator |
| 04/09/2008 | EP1907347A2 Compounds with activity at retinoic acid receptors |
| 04/09/2008 | EP1594867B1 Phenylacetamides and their use as glucokinase modulators |
| 04/09/2008 | EP1450796B1 Benzothiazole derivatives |
| 04/09/2008 | CN101160296A 5- [4- (4- (2 -amino- 2 -methoxycarbonylethyl) phenoxy) benzilidene] thiazolidin-2, 4-dion e derivatives and related compounds for reducing glucose, cholesterol and triglyceride levels in plasma |
| 04/09/2008 | CN101157664A New method for synthesizing rubber vulcanization accelerator CZ |
| 04/09/2008 | CN101157663A Method for producing rubber vulcanization accelerator NS |
| 04/09/2008 | CN101157662A Method for producing rubber vulcanization accelerator MBT |
| 04/09/2008 | CN100379731C Continuous process for the preparation of pesticidal chlorothiazoles |
| 04/09/2008 | CN100379725C Immunoassay detection method for neonicotinyl insecticides |
| 04/08/2008 | US7355049 Biaryloxymethylarenecarboxylic acids as glycogen synthase activator |
| 04/08/2008 | US7354946 Biarylurea derivatives |